Ramandeep is a researcher, analyst, writer and health economics and outcome research (HEOR) professional with 7+ years of experience in the pharmaceutical and biotechnology industry. Skilled in conducting systematic literature reviews (SLRs), targeted literature reviews (TLRs), statistical analysis plans, network meta-analysis (NMA), and indirect treatment comparison (ITC). In addition, expertise in burden of illness (BOI), pharmacoepidemiology, and market access projects, including developing publications for real world evidence generation. Experience across therapeutic areas, including but not limited to Acute Myeloid Leukemia (AML), Breast Cancer, Chronic Lymphocytic Leukemia (CLL), Cutaneous melanoma, Diffuse Large B-Cell Lymphoma (DLBCL), Multiple Myeloma (MM), Metastatic Castration Resistant Prostate Cancer (mCRPC), Metastatic Hormone Sensitive Prostate Cancer (mHSPC), Mucosal Melanoma, Myelodysplastic Syndrome (MDS), MSI-H Colorectal cancer (MSI-H CRC), Non-Muscle Invasive Bladder Cancer (NMIBC), Non-Small Cell Lung Cancer (NSCLC), Platinum Resistant Ovarian Cancer (PROC), Thrombocytopenia, Chronic Kidney Disease (CKD), Chronic Hepatitis B, Systemic Lupus Erythematosus (SLE), Borderline Personality Disorder, Chronic Migraine, Chronic graft versus Host disease (cGVHD), Dilated Cardiomyopathy, Hypercholesterolemia, Osteoarthritis, and Rare Diseases.

Interests/hobbies: Listening to music and painting.